5-Amino-1MQ is not FDA approved as a standard treatment for anti-aging, fat loss, insulin resistance, cardiovascular disease, or general wellness
It is likely that the larger number of statistically significant changes to the microbiome observed in the groups switched from WD to LD reflects their more numerous exposures to different diets, longitudinal changes in dietary exposure, the stress associated with diet switch, the negative energy state achieved by treatment and/or diet-driven weight loss, or a combination of these factors, but it may also be related to differences in terminal body weight and fat mass since both adiposity and diet composition have been shown to modulate the mouse gut microbiome profile
Comprehensive documentation of treatment rationale, patient consent processes, and clinical monitoring should be maintained given the experimental nature of these interventions and potential regulatory scrutiny
A comprehensive medical review helps identify potential risks, medication interactions, and whether treatment is appropriate for the individuals goals. Dr